REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
Recruiting
Observational Study
Acute Ischemic Stroke
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- Medtronic Neurovascular Clinical Affairs · Industry
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Post-Market Registry
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
2. Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device\* during treatment for acut…
Contacts